近日,国际制药界知名的专业杂志美国《制药经理人》(Pharm Exec)在其官网公布“2025 全球制药企业50强”(TOP50)榜单。该榜单自2000年起连续25年依据处方药销售业绩对全球生物制药企业进行权威排名,石药集团荣登榜单,位列第48位,创新实力获得国际认可。榜单报告指出,在行业颠覆与转型不断加剧的背景下,企业在抓住创新机会的同时坚守自身优势尤其重要。石药集团能多次上榜,正是得益于在创新...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.